Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/39265
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tokgun, O | - |
dc.contributor.author | Akca, Hakan | - |
dc.date.accessioned | 2022-02-28T07:13:50Z | - |
dc.date.available | 2022-02-28T07:13:50Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2147-2270 | - |
dc.identifier.uri | https://hdl.handle.net/11499/39265 | - |
dc.description.abstract | Kidney cancer takes at 3rd place within urogenital cancers following prostate and bladder cancer. Smoking, obesity, sedentary life, hipertension, nutrition habituation, job, chronic kidney insufficiency, urinary system infection and family history are some of the factors that play role in development of kidney cancer. | en_US |
dc.description.abstract | Kidney cancers have two forms including both sporadic and familial forms. In the ethiology of genetically inherited renal cell carcinomas Von Hippel Lindau, Hereditary leiomyomatosis, Birt Hogg Dube syndrome, adult polycyctic kidney, tuberosclerozis, neuroblastoma, malign lymphoma etc are prescribed as important risk factors. In the ethiology of renal cell carcinomas obesity, diet, body mass index, smoking are prescribed as important risk factors. | en_US |
dc.description.abstract | There are many factors such as gender, race, age, stage, distant metastasis, tumor size, DNA ploidy, cell proliferation, p53 overexpression, MUC1 expression, CD44s expression, Ki67, p21, Bcl- 2, PTEN, MDR and chromosomal abberations are related with the prognosis. | en_US |
dc.description.abstract | In the patients who are diagnosed as cancer, determining tumor behavior and prognostic factors earlier is important for treatment strategy. But still there are too many questions about thisIn this review we aimed to give a general information about genetic alterations which impacts tumor behavior. | en_US |
dc.language.iso | tr | en_US |
dc.publisher | GALENOS YAYINCILIK | en_US |
dc.relation.ispartof | UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Kidney cancer; p53; urinary system; Ki67; CD44 | en_US |
dc.title | Genetic alterations in kidney cancer | en_US |
dc.type | Review | en_US |
dc.identifier.volume | 12 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 155 | - |
dc.identifier.startpage | 155 | en_US |
dc.identifier.endpage | 162 | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.wos | WOS:000219391800005 | en_US |
dc.owner | Pamukkale University | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | tr | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.openairetype | Review | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
WEB OF SCIENCETM
Citations
1
checked on Nov 21, 2024
Page view(s)
30
checked on Aug 24, 2024
Google ScholarTM
Check
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.